MAP3K5 and intrahepatic cholangiocarcinoma: MAP3K5 is a participant in the MAPK signaling cascade and is normally inactivated by thioredoxin binding, whose activity was activated by Chaetocin in ICC cells, and then directly activated the downstream JNK pathway to induce cell apoptosis [47].